abstract |
The present invention relates to a method for treating cancer. In particular, the present invention provides a method for treating cancer by administering an Aurora kinase inhibitor in combination with an anti-CD30 antibody. Co-administration of an Aurora kinase inhibitor and anti-CD30 antibody can be performed simultaneously, separately, sequentially or sequentially. In one particular embodiment, the anti-CD30 antibody is an antibody-drug conjugate against CD30. In one particular embodiment, the Aurora kinase inhibitor is an Aurora A kinase inhibitor. [Selection] Figure 1A |